• レポートコード:MRC2304D119 • 出版社/出版日:Transparency Market Research / 2023年1月27日 • レポート形態:英文、PDF、175ページ • 納品方法:Eメール • 産業分類:医療 |
Single User | ¥869,250 (USD5,795) | ▷ お問い合わせ |
Multi User | ¥1,319,250 (USD8,795) | ▷ お問い合わせ |
Corporate License | ¥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の当調査レポートでは、振動メッシュネブライザーの世界市場を分析し、市場実態を明らかにしています。本書は、序論、仮定&調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品種類別(アクティブメッシュネブライザー、パッシブメッシュネブライザー)分析、用途別(COPD、喘息、嚢胞性線維症、その他)分析、年齢層別(成人、小児)分析、流通チャンネル別(インライン、オフライン)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などを収録しています。また、Koninklijke Philips N.V.、OMRON Healthcare, Inc.、PARI GmbH、Jiangsu ABD Medical Devices Co., Ltd.、Aerogen、Hamilton Medical、Apex Medical Corp.、Feellife Medical Inc.、Vapo Healthcare Co., Ltd.、Lepu Medical Technology (Beijing) Co., Ltd.などの企業情報を掲載しています。 ・序論 ・仮定&調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の振動メッシュネブライザー市場規模:製品種類別 - アクティブメッシュネブライザーの市場規模 - パッシブメッシュネブライザーの市場規模 ・世界の振動メッシュネブライザー市場規模:用途別 - COPDの市場規模 - 喘息の市場規模 - 嚢胞性線維症の市場規模 - その他用途の市場規模 ・世界の振動メッシュネブライザー市場規模:年齢層別 - 成人用振動メッシュネブライザーの市場規模 - 小児用振動メッシュネブライザーの市場規模 ・世界の振動メッシュネブライザー市場規模:流通チャンネル別 - インラインチャンネルの市場規模 - オフラインチャンネルの市場規模 ・世界の振動メッシュネブライザー市場規模:地域別 - 北米の振動メッシュネブライザー市場規模 - ヨーロッパの振動メッシュネブライザー市場規模 - アジア太平洋の振動メッシュネブライザー市場規模 - 中南米のアルミニウムスラグ市場規模 - 中東・アフリカのアルミニウムスラグ市場規模 ・競争状況 |
Vibrating Mesh Nebulizer Market – Scope of Report
TMR’s report on the global vibrating mesh nebulizer market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global vibrating mesh nebulizer market for the period 2017–2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global vibrating mesh nebulizer market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the vibrating mesh nebulizer market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global vibrating mesh nebulizer market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global vibrating mesh nebulizer market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global vibrating mesh nebulizer market.
The report delves into the competitive landscape of the global vibrating mesh nebulizer market. Key players operating in the global vibrating mesh nebulizer market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global vibrating mesh nebulizer market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market vibrating mesh nebulizer.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
• Industry Sources:
o WorldWideScience.org
o Elsevier, Inc.
o National Institutes of Health (NIH)
o PubMed
o NCBI
o Department of Health Care Service
• Trade Data Sources
o Trade Map
o UN Comtrade
o Trade Atlas
• Company Information
o OneSource Business Browser
o Hoover’s
o Factiva
o Bloomberg
• Mergers & Acquisitions
o Thomson Mergers & Acquisitions
o MergerStat
o Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Vibrating Mesh Nebulizer Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Vibrating Mesh Nebulizer Market Analysis and Forecast, 2017 – 2031
4.4.1. Market Revenue Projection (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Key Product Type/Brand Analysis
5.2. Technological Advancements
5.3. COVID-19 Impact on Industry
6. Global Vibrating Mesh Nebulizer Market Analysis and Forecast, By Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast By Product Type, 2017 – 2031
6.3.1. Active Mesh Nebulizer
6.3.2. Passive Mesh Nebulizer
6.4. Market Attractiveness By Product Type
7. Global Vibrating Mesh Nebulizer Market Analysis and Forecast, By Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast By Application, 2017 – 2031
7.3.1. COPD
7.3.2. Asthma
7.3.3. Cystic Fibrosis
7.3.4. Others
7.4. Market Attractiveness By Application
8. Global Vibrating Mesh Nebulizer Market Analysis and Forecast, By Age Group
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast By Age Group, 2017 – 2031
8.3.1. Adults
8.3.2. Pediatrics
8.4. Market Attractiveness By Age Group
9. Global Vibrating Mesh Nebulizer Market Analysis and Forecast, By Distribution Channel
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast By Distribution Channel, 2017 – 2031
9.3.1. Online
9.3.2. Offline
9.4. Market Attractiveness By Distribution Channel
10. Global Vibrating Mesh Nebulizer Market Analysis and Forecast, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Vibrating Mesh Nebulizer Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product Type, 2017 – 2031
11.2.1. Active Mesh Nebulizer
11.2.2. Passive Mesh Nebulizer
11.3. Market Value Forecast By Application, 2017 – 2031
11.3.1. COPD
11.3.2. Asthma
11.3.3. Cystic Fibrosis
11.3.4. Others
11.4. Market Value Forecast By Age Group, 2017 – 2031
11.4.1. Adults
11.4.2. Pediatrics
11.5. Market Value Forecast By Distribution Channel, 2017 – 2031
11.5.1. Online
11.5.2. Offline
11.6. Market Value Forecast By Country, 2017 – 2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Application
11.7.3. By Age Group
11.7.4. By Distribution Channel
11.7.5. By Country
12. Europe Vibrating Mesh Nebulizer Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product Type, 2017 – 2031
12.2.1. Active Mesh Nebulizer
12.2.2. Passive Mesh Nebulizer
12.3. Market Value Forecast By Application, 2017 – 2031
12.3.1. COPD
12.3.2. Asthma
12.3.3. Cystic Fibrosis
12.3.4. Others
12.4. Market Value Forecast By Age Group, 2017 – 2031
12.4.1. Adults
12.4.2. Pediatrics
12.5. Market Value Forecast By Distribution Channel, 2017 – 2031
12.5.1. Online
12.5.2. Offline
12.6. Market Value Forecast By Country, 2017 – 2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Application
12.7.3. By Age Group
12.7.4. By Distribution Channel
12.7.5. By Country
13. Asia Pacific Vibrating Mesh Nebulizer Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product Type, 2017 – 2031
13.2.1. Active Mesh Nebulizer
13.2.2. Passive Mesh Nebulizer
13.3. Market Value Forecast By Application, 2017 – 2031
13.3.1. COPD
13.3.2. Asthma
13.3.3. Cystic Fibrosis
13.3.4. Others
13.4. Market Value Forecast By Age Group, 2017 – 2031
13.4.1. Adults
13.4.2. Pediatrics
13.5. Market Value Forecast By Distribution Channel, 2017 – 2031
13.5.1. Online
13.5.2. Offline
13.6. Market Value Forecast By Country, 2017 – 2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Application
13.7.3. By Age Group
13.7.4. By Distribution Channel
13.7.5. By Country
14. Latin America Vibrating Mesh Nebulizer Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product Type, 2017 – 2031
14.2.1. Active Mesh Nebulizer
14.2.2. Passive Mesh Nebulizer
14.3. Market Value Forecast By Application, 2017 – 2031
14.3.1. COPD
14.3.2. Asthma
14.3.3. Cystic Fibrosis
14.3.4. Others
14.4. Market Value Forecast By Age Group, 2017 – 2031
14.4.1. Adults
14.4.2. Pediatrics
14.5. Market Value Forecast By Distribution Channel, 2017 – 2031
14.5.1. Online
14.5.2. Offline
14.6. Market Value Forecast By Country, 2017 – 2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Application
14.7.3. By Age Group
14.7.4. By Distribution Channel
14.7.5. By Country
15. Middle East & Africa Vibrating Mesh Nebulizer Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Product Type, 2017 – 2031
15.2.1. Active Mesh Nebulizer
15.2.2. Passive Mesh Nebulizer
15.3. Market Value Forecast By Application, 2017 – 2031
15.3.1. COPD
15.3.2. Asthma
15.3.3. Cystic Fibrosis
15.3.4. Others
15.4. Market Value Forecast By Age Group, 2017 – 2031
15.4.1. Adults
15.4.2. Pediatrics
15.5. Market Value Forecast By Distribution Channel, 2017 – 2031
15.5.1. Online
15.5.2. Offline
15.6. Market Value Forecast By Country, 2017 – 2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Application
15.7.3. By Age Group
15.7.4. By Distribution Channel
15.7.5. By Country
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis By Company (2021)
16.3. Company Profiles
16.3.1. Koninklijke Philips N.V.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Type Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. OMRON Healthcare, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Type Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. PARI GmbH
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Type Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Jiangsu ABD Medical Devices Co., Ltd.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Type Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Aerogen
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Type Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Hamilton Medical
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Type Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Apex Medical Corp.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Type Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Feellife Medical Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Type Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Vapo Healthcare Co., Ltd.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Type Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Lepu Medical Technology (Beijing) Co., Ltd.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Type Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview